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A conserved ubiquitin ligase
of the nuclear envelope/endoplasmic
reticulum that functions in both
ER-associated and Mat␣2
repressor degradation
Robert Swanson,1 Martin Locher,2 and Mark Hochstrasser2,3
1
Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, Illinois 60637, USA; 2Department
of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06520, USA

Substrate discrimination in the ubiquitin–proteasome system is believed to be dictated by specific
combinations of ubiquitin–protein ligases (E3s) and ubiquitin-conjugating enzymes (E2s). Here we identify
Doa10/Ssm4 as a yeast E3 that is embedded in the endoplasmic reticulum (ER)/nuclear envelope yet can target
the soluble transcription factor Mat␣2. Doa10 contains an unusual RING finger, which has ubiquitin-ligase
activity in vitro and is essential in vivo for degradation of ␣2 via its Deg1 degradation signal. Doa10 functions
with two E2s, Ubc6 and Ubc7, to ubiquitinate Deg1-bearing substrates, and it is also required for the
degradation of at least one ER membrane protein. Interestingly, different short-lived ER proteins show distinct
requirements for Doa10 and another ER-localized E3, Hrd1. Nevertheless, the two E3s overlap in function: A
doa10⌬ hrd1⌬ mutant is far more sensitive to cadmium relative to either single mutant and displays strong
constitutive induction of the unfolded protein response; this suggests a role for both E3s in eliminating
aberrant ER proteins. The likely human ortholog of DOA10 is in the cri-du-chat syndrome critical region on
chromosome 5p, suggesting that defective ubiquitin ligation might contribute to this common genetic
disorder.
[Key Words: Ubiquitin; ERAD; proteasome; protein degradation; UPR]
Received July 31, 2001; revised version accepted August 28, 2001.

Selective protein degradation plays an essential role in a
diverse array of biological processes. The most common
mechanism for degrading intracellular proteins in eukaryotes uses the ubiquitin–proteasome system. In this
system, polymers of ubiquitin, a 76-residue protein, are
conjugated to a substrate protein, resulting in recognition and destruction of the substrate by the 26S proteasome (Hochstrasser 1996; Pickart 2001; Weissman 2001).
For ubiquitin–protein conjugation, the C-terminal carboxyl group of ubiquitin is first activated in an energydependent reaction by the ubiquitin-activating enzyme
(E1), followed by transfer of the ubiquitin to a ubiquitinconjugating enzyme (E2) via transthiolation. The E2, together with a third factor called a ubiquitin–protein ligase or E3, transfers ubiquitin to a lysine side-chain(s) of
a target protein. E3s are factors that stimulate the E2dependent ubiquitination of substrates (Reiss et al.
1989).
3
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The E3 proteins are thought to be largely responsible
for the high degree of specificity in protein ubiquitination. For instance, the Rsp5 E3 enzyme ubiquitinates the
large subunit of RNA polymerase II, and WW domains in
Rsp5 interact directly with a repeated proline-rich motif
(PxY) in the polymerase subunit (Chang et al. 2000).
Whereas E1 and E2 components of the ubiquitin conjugation machinery can be readily identified by their signature sequence motifs, E3s have not been as easily categorized. However, known E3s divide into two heterogeneous families (Weissman 2001). E3s of the HECT
domain family have a ∼350-residue domain that includes
a conserved Cys residue, which attacks the ubiquitin–E2
to form another thioester intermediate before ubiquitin
transfer to substrate. The second group of E3s comprise
the RING finger family. RING fingers bind two zinc atoms in a characteristic “cross-brace” arrangement of coordinating Cys and His residues and can bind directly to
the E2 (Zheng et al. 2000).
Surprisingly, the ubiquitin–proteasome system is also
responsible for the degradation of membrane and lumenal proteins of the endoplasmic reticulum (ER) (for
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review, see Plemper and Wolf 1999). This ER-associated
degradation (ERAD) requires retrotranslocation of proteins or protein segments back into the cytoplasm, a process often mediated by the same Sec61 translocon responsible for anterograde translocation of ER proteins.
Ubc1, Ubc6, and Ubc7 are the primary E2s responsible
for ERAD, whereas Hrd1/Der3, a RING finger protein, is
the only known E3 that participates in this process, although additional ERAD E3s are likely to exist (Plemper
and Wolf 1999; Friedlander et al. 2000; Hill and Cooper
2000; Wilhovsky et al. 2000; Bays et al. 2001). Ubc6,
Ubc7, and Hrd1 all localize to the ER/nuclear envelope.
Our studies of the ubiquitin system have focused on
the short-lived transcriptional repressor Mat␣2 in the
yeast Saccharomyces cerevisiae (Hochstrasser et al.
1999). Previously, we identified two distinct ubiquitination pathways that are both required for normal rates of
␣2 degradation (Chen et al. 1993). The first of these involves the closely related E2s Ubc4 and Ubc5 and recognizes an as-yet-undefined degradation signal in ␣2. The
second pathway uses Ubc6 and Ubc7; this pathway recognizes a degradation signal within the N-terminal 62
residues of ␣2, which we named Deg1. A key determinant of the Deg1 signal is the exposed hydrophobic face
of an amphipathic helix, which we had suggested could
be a recognition site for an E3 or E2/E3 complex (Johnson
et al. 1998). Despite several previous screens for doa
(degradation of alpha2) mutants, no E3 that ubiquitinates
␣2 had been identified (Hochstrasser et al. 1999; Swanson and Hochstrasser 2000). Here we describe a new genetic selection that has led to the identification of
Doa10, a novel RING finger E3 that promotes the ubiquitination of Deg1-containing proteins. Doa10 is also
shown to be required for the degradation of an integral
ER membrane protein. The Doa10 ubiquitin ligase has
an overlapping role with Hrd1/Der3 in promoting ERassociated degradation and negatively regulating the ER
unfolded protein response.
Results
Genetic selection for Deg1–protein degradation defects
We devised a mutant selection strategy that took advantage of the fact that fusion of the Deg1 degradation signal
to Ura3, an enzyme required for uracil biosynthesis, creates a short-lived fusion product. Rapid degradation of
Deg1–Ura3 severely impairs growth of wild-type cells on
media lacking uracil when this protein is the only source
of Ura3 activity (Chen et al. 1993). A selection for mutants in which Deg1–Ura3 was long lived offered two
principal advantages in a search for an E3. First, the positive growth selection allowed a large number of mutants
to be examined. Second, the selection is biased against
proteasome mutants and mutants involved in general
ubiquitin metabolism because most of these genes are
essential. A strain with one of these genes mutated may
express a more stable Deg1–Ura3 fusion but would not
be isolated because of its concomitant poor growth. In
contrast, yeast cells lacking Ubc6 and Ubc7, the E2s that

act through Deg1, are not growth compromised, so we
hypothesized that the E3 for Deg1 also would not be
necessary for rapid growth.
Deg1–URA3 ura3 cells were mutagenized and plated
on minimal medium lacking uracil (SD-ura). We recovered 960 mutants that grew rapidly. To avoid characterizing mutations in genes already known to act in Deg1mediated degradation, the mutants were tested for their
ability to complement the following mutants: ubc6⌬
ubc7⌬; cue1⌬, which lacks an accessory factor for Ubc7
(Biederer et al. 1997); doa4⌬, which is missing a deubiquitinating enzyme required for ubiquitin homeostasis
(Swaminathan et al. 1999); and rpn4, which is defective
for a nonessential regulator of the proteasome (Mannhaupt et al. 1999; Swanson and Hochstrasser 2000). Of
the isolated mutants, 602 were mutated in UBC6 and/or
UBC7 (Table 1, group I), and none was defective for any
of the other tested genes. Analysis of the remaining mutants revealed three additional complementation groups.
The group II mutants carried a recessive mutation in a
single gene, which we named DOA10. These mutants
had no discernable growth defect on rich media and
showed robust growth on SD-ura (Fig. 1A). Mutant
doa10 cells were not hypersensitive to high or low temperatures, to the amino-acid analog canavanine, or to
cadmium (see Fig. 7A, below; data not shown); such defects are common among mutants with a global disruption of ubiquitin-mediated proteolysis. To confirm that
the enhanced growth of doa10 cells on SD-ura was
caused by stabilization of Deg1-containing substrates,
the degradation of a Deg1–␤-galactosidase protein (Deg1–
␤gal) was examined by pulse-chase analysis (Fig. 1B). In
wild-type cells, Deg1–␤gal has a half-life of <15 min, but
very little was degraded in doa10 cells during the 45-min
chase. Therefore, doa10 cells do not display aberrations
associated with global defects in the ubiquitin–proteasome system, but they have a striking defect in the degradation of Deg1-containing substrates.
The group III mutant phenotype was also recessive but
resulted from mutations in two unlinked genes, which
we called DOA11 and DOA12. Whereas the doa11-1
doa12-1 double mutant grew well on SD-ura, the
doa11-1 and doa12-1 strains grew poorly (Fig. 1A). Consistent with these growth characteristics, mutations in
both DOA11 and DOA12 were needed for strong perturbation of Deg1-mediated degradation (Fig. 1C). The
doa11-1 mutant, but not doa12-1, was also somewhat
hypersensitive to cadmium but displayed no other obvious abnormalities (data not shown). Finally, the single

Table 1.

Mutant doa complementation groups
Complementation

Group
I
II
III
IV

No. isolates

Mutant

602
356
1
1

ubc6/doa2 and/or ubc7
doa10
doa11-1 doa12-1
DOA13-1
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genomic yeast DNA libraries were unsuccessful. We resorted to localizing the DOA10 gene by genetic mapping
(see Materials and Methods). Following assignment of
DOA10 to chromosome IX, the doa10-2 allele was finemapped by meiotic mapping. The doa10-2 strain was
mated to a strain in which the ULP2 gene on chromosome IX was replaced with HIS3 (Li and Hochstrasser
2000). After sporulation of the resulting diploid, 96 complete tetrads were dissected. Surprisingly, no recombination between the doa10-2 and ulp2⌬⬋HIS3 alleles was
detected, indicating very tight linkage of the two loci
(<0.5 cM). One of the genes flanking ULP2 is SSM4/
YIL030c. SSM4 had been identified by a mutation that
suppressed the temperature-sensitive growth of an
rna14-1 mutant, but the biochemical function of Ssm4
was unknown (Mandart et al. 1994). We regarded this
gene as a likely candidate for DOA10 for two reasons.
First, SSM4 had been shown to be toxic in Escherichia
coli, which could explain our inability to clone DOA10,
inasmuch as the yeast DNA libraries were maintained in
E. coli hosts. Second, the predicted protein had a putative
RING finger (Fig. 2A), which would be consistent with it
being a ubiquitin ligase.
To confirm that SSM4 was DOA10, the SSM4 coding
sequence was replaced by HIS3. Degradation of Deg1–
␤gal in the ssm4⌬::HIS3 strain was severely inhibited
(data not shown). Furthermore, the ssm4⌬ strain failed to
complement the Deg1–Ura3 proteolytic defect when
mated to several different doa10 strains isolated in our
selection. These complementation and mapping results
show that SSM4 and DOA10 are the same gene.
Doa10 structural features

Figure 1. Characterization of new doa mutants. (A) Wild-type
and doa mutant strains were grown on rich medium (YPD) and
minimal plates lacking uracil (−URA). (B) Pulse-chase analysis
of Deg1–␤gal in wild-type and doa10-2 strains. (C) Degradation
kinetics of Deg1-␤gal in wild-type, doa11-1, doa12-1, and
doa11-1 doa12-1 strains. Proteins were precipitated with antibodies to ␤gal for B and C.

group IV mutant carried a dominant mutation in a gene
we named DOA13. DOA13-1 cells were hypersensitive
to various stress conditions, which suggested that this
mutant had a widespread defect in ubiquitin-mediated
degradation (data not shown).
Because mutations in DOA10 were isolated repeatedly
and had such a strong effect on Deg1-containing substrates, DOA10 was chosen for further study.
Identification of the DOA10 gene
Attempts to clone DOA10 through complementation of
the recessive doa10 degradation defect using multiple
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DOA10 is predicted to encode a 151-kD protein that includes segments bearing similarity to several known protein motifs. As noted above, one such motif is a RING
finger, which resides in the N-terminal 100 residues of
Doa10 (Fig. 2A). The classical RING finger (RING-HC)
has a histidine at the fourth coordinating position and a
cysteine at the fifth. In the RING-H2 variant, both the
fourth and fifth positions are occupied by histidines. The
Doa10 RING, which is very similar to the RING finger
in the human TEB4 protein (Fig. 2A), differs from both of
these variants in that it has a Cys residue in the fourth
position and a His in the fifth. We suggest calling this
widespread variant a RING-CH finger. Another difference between Doa10 and the common RING variants is
a somewhat longer peptide segment between the fourth
and fifth zinc-coordinating residues.
A second motif found in Doa10 is a WW domain at
residues 775 to 807 (Fig. 2B). The WW domain is a motif
of ∼32 to 40 residues (Kasanov et al. 2001). It has been
found in several HECT-class E3s, in which it can function as either a substrate- or cofactor-binding site. WW
motifs fall into several sequence subclasses with characteristic peptide binding preferences. Many type I WW
domains, for example, bind to proline-rich PPxY motifs
in target proteins. Although the Doa10 WW domain cannot be placed easily in any of the known subclasses, it is
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Figure 2. Doa10 structural features. (A) Alignment of the closely related yeast Doa10 and human TEB4 RING fingers with examples
of a RING-HC finger (human c-Cbl) and a RING-H2 finger (yeast Hrd1). The metal-coordinating His and Cys residues are highlighted
in gray, as is the Trp residue commonly found in RING finger ubiquitin ligases. An 11-residue segment after residue 359 of Hrd1 was
removed for clarity. (†) Residues in the c-Cbl RING that contact the E2 in the c-Cbl–UbcH7 structure (Zheng et al. 2000). (B) The
Doa10 WW domain compared to two other yeast non-type-I WW motifs. The consensus sequence is from Kasanov et al. (2001). (␦)
hydrophilic; (⌰) aromatic. (C) Similar membrane topology predicted from hydropathy plots of S. cerevisiae Doa10 and its likely
orthologs in S. pombe (SPBC14F5.07) and humans (TEB4; GenBank KIAA0597). The predicted human protein lacks several internal,
poorly conserved segments shared by the two yeast proteins. (D) The TEB4–Doa10 (TD) domain. The same proteins as in C are
compared.

intriguing that Ubc6 is unique among the yeast E2s in
that it bears a PPxY motif (PPPY). Motif-searching algorithms also predict that Doa10 contains 10 to 14 trans-

membrane segments, suggesting that it is an integral
membrane protein (Fig. 2C).
Doa10 is related to predicted proteins in Schizosaccha-
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romyces pombe, Arabidopsis thaliana, Drosophila melanogaster, Caenorhabditis elegans, and Homo sapiens.
Similarity among these proteins, none of which had a
previously described function, is concentrated in two
segments. The N-terminal regions that span the RING
finger are 29% to 43% identical to Doa10 (see Fig. 2A). A
number of shorter viral proteins also have RING domains closely related to the Doa10 finger. Both human
Kaposi’s sarcoma-associated herpesvirus IE1 proteins
and swinepox C7 protein have an N-terminal RING-CH
as well as several predicted transmembrane segments
(Nicholas et al. 1997), suggesting that these viruses can
redirect the cellular ubiquitination machinery to facilitate virus reproduction. The second region of similarity
is an internal block of ∼130 residues that shows 27% to
37% identity to Doa10 (Fig. 2D); we call this region the
TEB4–Doa10 (TD) domain. The TD domain appears to be
unique to the Doa10-homologous proteins, which also
all contain N-terminal RING-CH fingers. Finally, comparisons of hydropathy profiles for the predicted orthologs strongly suggest that they also all share similar
membrane topologies; this is particularly clear in their
C-terminal regions (Fig. 2C).
Doa10 is an integral membrane protein that localizes
to the ER
The predicted transmembrane disposition of Doa10 led

Figure 3. Doa10 is an integral membrane
protein of the ER/nuclear envelope. (A)
MHY1657 cells expressing myc9-tagged
Doa10 were stained with an antibody to the
myc epitope, an antibody to Kar2, and the
Hoechst 33258 dye. (B) GFP fluorescence visualized by confocal microscopy in MHY1658
cells expressing a fusion between Doa10
and GFP. (C) Subcellular fractionation of
MHY1690 cells carrying pHA-UBC7. Cell
lysates were divided into microsomal pellet
and supernatant fractions, which were examined by immunoblotting. Lysates were
treated with buffer alone or buffer containing 1% Triton X-100 and 0.5 M NaCl (Triton, salt), 0.1 M Na2CO3 at pH 11.5, 0.5 M
NaCl (salt), or 2.5 M urea. (P) pellet; (S) supernatant.
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us to examine its cellular localization using both microscopy and cell fractionation. Immunofluorescent staining
of a functional Doa10 derivative tagged at its C terminus
with nine myc epitopes (Doa10–myc) revealed bright
perinuclear staining as well as more peripheral stained
structures (Fig. 3A). The pattern was reminiscent of ER
staining. This was confirmed in double-labeling experiments, which showed nearly identical staining by antibodies directed against Doa10–myc and against the ER
chaperone Kar2. The same ER staining pattern was observed in live cells expressing a functional fusion between Doa10 and GFP (Fig. 3B).
To verify that Doa10 is an integral membrane protein,
subcellular fractionation was performed. Cells were gently lysed and then separated by high-speed centrifugation
into pellet and supernatant fractions after various treatments (Fig. 3C). Doa10–myc could be extracted from the
membrane pellet with detergent plus salt, a condition
that solubilizes membranes. In contrast, salt or urea
treatments that strip peripheral membrane proteins
could not extract Doa10–myc nor could sodium carbonate (pH 11.5), which strips peripheral membrane proteins
and releases lumenal ER proteins such as GFP-HDEL, a
model lumenal ER protein (Rossanese et al. 2001). Ubc7
was used as a peripheral membrane protein control. It
was substantially solubilized by sodium carbonate or
urea but not by salt. Pgk1 (phospho-glycerate kinase)
fractionated as expected for a cytosolic protein. There-
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fore, by multiple biochemical and cell biological criteria,
Doa10 is an integral membrane protein that localizes
primarily to the ER/nuclear envelope, the same localization as the Ubc6 and Ubc7 enzymes.

Substrate specificity of Doa10
E3s are expected to show a high degree of substrate specificity. To gauge the range of ubiquitin pathway substrates that require Doa10, additional substrates were
examined. Neither degradation of Leu-␤gal, a substrate
for the N-end rule pathway, nor that of Ub-Pro-␤gal, a
UFD pathway substrate (Varshavsky 1997), was affected
by deletion of DOA10 (Fig. 4A; data not shown). We also
tested an ERAD substrate, CPY*, the degradation of
which requires two of the same E2s, Ubc6 and Ubc7, that
act in the DOA pathway (Chen et al. 1993; Hiller et al.
1996). CPY* is a mutant version of the vacuolar carboxypeptidase Y. CPY* is retained in the ER, ejected into the
cytoplasm, and degraded by the proteasome (Hiller et al.
1996). In wild-type cells, CPY* had a half-life of ∼15 min,
whereas in ubc6 ubc7 cue1 cells, its degradation was
severely compromised (Fig. 4B). In contrast, CPY* degradation kinetics were identical in wild-type and doa10⌬
cells. These data also indicate that Ubc6, Ubc7, and
Cue1 are still active in doa10⌬ cells.
Very recently, it has been shown that the transmembrane Ubc6 protein is itself a relatively short-lived protein with a constitutive degradation that depends on
Ubc7, Cue1, and the proteasome (but not on Hrd1 or
Sec61; Walter et al. 2001). Moreover, a catalytically inactive Ubc6 mutant is not degraded, even in cells that
also express a wild-type version of the E2. The requirement for both Ubc6 activity in cis and for Ubc7 in Ubc6
ubiquitination suggests that these E2s assemble into a
complex, as had been proposed previously (Chen et al.
1993). If Doa10 were also part of this complex, one would
expect doa10 mutants to be defective for Ubc6 degrada-

tion as well. This was precisely what was observed (Fig.
4C). Ubc6 was not detectably degraded during the 3-h
chase period, and its steady state levels were increased
relative to wild-type. Therefore, Doa10 is capable of targeting not only soluble proteins for degradation but also
integral ER membrane proteins.
As noted above, the ␣2 protein is degraded by at least
two distinct pathways. If either the Ubc4/Ubc5 or the
Ubc6/Ubc7 pathway alone is disrupted, ␣2 degradation is
slowed only two- to threefold, but if both are blocked, a
synergistic inhibition is seen, with ␣2 half-life increasing
10- to 15-fold (Fig. 5A,B; Chen et al. 1993). We tested
whether Doa10 functioned only with Ubc6 and Ubc7,
which target the Deg1 signal of ␣2, or with both Ubc4/5
and Ubc6/7. Degradation of ␣2 was inhibited ∼threefold
in doa10⌬ cells (Fig. 5A), consistent with Doa10 acting
in only one of the two pathways. Doa10 was confirmed
to be in the Ubc6/Ubc7 pathway based on the finding
that in a ubc6⌬ doa10⌬ double mutant, the half-life of ␣2
was no higher than that in the single mutants (Fig. 5A).
In contrast, simultaneous deletion of UBC4 and DOA10
led to a striking inhibition of ␣2 degradation, indicating
that both the Ubc4/5 and Ubc6/7 ␣2 ubiquitination pathways were blocked in this mutant (Fig. 5A,B).
Hence, Doa10 has a substrate specificity even more
restricted than that of the E2s that act in ␣2 turnover,
and it functions specifically in the Deg1-mediated Ubc6/
Ubc7 pathway of ␣2 degradation.
Doa10 is required for Deg1-mediated ubiquitination
In light of the data described above, the most likely hypothesis for the mechanism of Doa10 action is that it
stimulates the ubiquitination of Deg1-containing substrates. To test this, the levels of ubiquitin-Deg1–␤gal
conjugates were monitored (Fig. 6A). Deg1–␤gal was immunoprecipitated from yeast cell extracts and then analyzed by anti-ubiquitin immunoblotting. In wild-type

Figure 4. Doa10 shows high substrate
specificity in vivo. (A) Degradation kinetics of the N-end rule substrate Leu–␤gal in
wild-type (MHY501) and doa10⌬ strains
(MHY1631) carrying the plasmid p415GPDUb-L-lacZ. Radiolabeled proteins were precipitated with an antibody to ␤gal. (B) Degradation kinetics of CPY* in wild-type and
mutant strains. Radiolabeled proteins were
precipitated with an antibody to CPY. (C)
Degradation of Ubc6. At time zero, cycloheximide was added, and disappearance of
Ubc6 was followed by anti-Ubc6 immunoblotting.
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Deg1–␤gal with an inactivating Deg1 point mutation
(Johnson et al. 1998; J. Laney and M. Hochstrasser, unpubl.). No ubiquitinated Deg1–␤gal was detected in either ubc6⌬ ubc7⌬ or doa10⌬ cells (Fig. 6A, lanes 1–4).
Therefore, Doa10 is required in vivo for the ubiquitination of Deg1 substrates.
A number of E3s in yeast are known to be present at
limiting levels in vivo, and overproduction can enhance
rates of substrate proteolysis (Bartel et al. 1990; Bays et
al. 2001). Similarly, overexpression of DOA10 resulted
in a reproducible two- to threefold increase in the rate of

Figure 5. Mat␣2 degradation in mutant cells. (A) Pulse-chase
analysis of ␣2 in wild-type cells and congenic deletion mutants.
Proteins were precipitated with an antibody to ␣2. (B) Quantitation of the pulse-chase data in A for MHY501, MHY503, and
MHY1648. (C) Deg1–␤gal degradation in wild-type cells
(MHY501) carrying the plasmid YEp13–Deg1–lacZ and either
full-length DOA10 under the control of a strong promoter on a
2-µm plasmid (pGPD–DOA10) or the empty vector (pGPD). Proteins were precipitated with an antibody to ␤gal.

cells, polyubiquitinated Deg1–␤gal species were detected, and the levels of these species were enhanced by
ubiquitin overexpression (Fig. 6A, lanes 5,6). These conjugates were not detected in cells that did not express
Deg1–␤gal (Fig. 6A, lanes 7,8) or expressed a mutant
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Figure 6. Function of the Doa10 RING finger in vivo and in
vitro. (A) Anti-ubiquitin immunoblot analysis of immunoprecipitated Deg1–␤gal from cells carrying YEplac195–Deg1–lacZ
or empty vector. Strains also contained a plasmid for overexpression of ubiquitin (+Ub) or an empty vector. Proteins were
immunoprecipitated with antibodies to ␤gal. (Lower panel) The
same blot reprobed with antibodies against ␤gal. (B) Degradation of Deg1–␤gal in wild-type and doa10–C39S cells. Proteins
were precipitated with an antibody to ␤gal. (C) In vitro ubiquitin
ligase activity of the Doa10 RING domain. (Lanes 1,2) Complete
reactions, including S protein substrate. In the reaction with S
peptide, 1.5 µg of competitor peptide was added (lane 2). Ubiquitin–S protein conjugates (Ubn-S) are indicated. Omitted components are indicated above lanes 5–9, and no S protein was
added in the zinc chelation experiment shown in lanes 3 and 4.
Ubiquitinated proteins were detected by anti-ubiquitin immunoblotting. Open arrowhead indicates position of unmodified S
protein.
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Deg1–␤gal degradation (Fig. 5C). We also observed an
increase in levels of ubiquitinated Deg1–␤gal when
Doa10 was overexpressed (data not shown), suggesting
that enhanced ubiquitination of the substrate accounts
for its accelerated degradation under these conditions.

The Doa10 RING finger is required in vivo and has
ubiquitin ligase activity in vitro
The RING fingers found in many E3s are essential for
their ability to catalyze substrate ubiquitination and degradation (Weissman 2001). To investigate whether the
putative RING finger in Doa10 plays a role in Deg1mediated degradation, the first cysteine in the RING
consensus sequence was mutated to a serine (C39S). Epitope-tagged Doa10 derivatives from both DOA10 and
doa10-C39S strains were expressed at similar levels (data
not shown). However, degradation of Deg1–␤gal was
strongly impaired in doa10-C39S cells (Fig. 6B). Therefore, the RING-CH finger of Doa10 is crucial for Doa10dependent proteolysis in vivo.
These in vivo data strongly suggest that Doa10 is the
E3 ubiquitin ligase for the DOA pathway. To examine
directly the ability of the Doa10 RING to catalyze the
transfer of ubiquitin to another protein, a GST-S peptide–Doa10RING fusion was purified from E. coli and
used in an in vitro ubiquitination assay with purified
recombinant E1, E2, ubiquitin, and ATP. The 15-residue
S peptide segment allows binding of GST-S–Doa10RING
to S protein, which was added as substrate to the in vitro
reaction (Bays et al. 2001). GST-S–Doa10RING catalyzed
efficient ubiquitination of S protein (Fig. 6C, lane 1).
Ubiquitination was prevented by omission of any single
component of the reaction (Fig. 6C, lanes 5–9) or by adding an excess of competitor S peptide (Fig. 6C, lane 2),
suggesting that the RING protein must bind the substrate to catalyze E2-dependent ubiquitin transfer. The
RING fingers of many E3s catalyze polyubiquitination of
themselves in vitro (Lorick et al. 1999), and high molecular mass ubiquitinated species also accumulated in reac-

tions with the Doa10 RING finger (Fig. 6C). Based on our
ability to reisolate a substantial fraction of these species
on glutathione-Sepharose (data not shown) and their
presence even in the absence of added S protein (Fig. 6C,
lanes 4,5), we expect that most are polyubiquitinated
GST-S–Doa10RING. Removal of zinc from GST-S–
Doa10RING with the zinc chelator TPEN, which will disrupt the RING finger, destroyed its ligase activity, but
activity was restored by reintroduction of zinc ions (Fig.
6C, lanes 3,4; no S protein added). We conclude that
Doa10 is a ubiquitin–protein ligase.

Functional overlap of Doa10 and Hrd1
Doa10 and Hrd1 are the only known E3s that reside in
the ER. The two proteins clearly have distinct substrate
specificities in vivo (Fig. 4). However, their similar localization and common cofactors led us to investigate
whether there might nevertheless be some overlap in
their function. We created a hrd1⌬ doa10⌬ double mutant and asked whether any phenotypic abnormalities
could be detected in this strain that were not seen in the
single mutants. The double mutant grew normally at
30°C and 37°C, but when plated on medium containing
cadmium, a pronounced growth defect was observed (Fig.
7A). The hrd1⌬ single mutant is slightly hypersensitive
to cadmium, but the hrd1⌬ doa10⌬ strain grew at least
as poorly as a ubc7⌬ mutant, which is known to be extremely sensitive to the heavy metal. The mechanistic
basis of cadmium sensitivity is not known, but these
results indicate that Doa10 and Hrd1 both participate in
maintaining normal resistance.
Loss of Hrd1-dependent ERAD leads to a modest increase in unfolded proteins in the ER, which in turn
causes a mild constitutive activation of the unfolded protein response (UPR; Friedlander et al. 2000). If Doa10
also contributes to the degradation of proteins in the ER,
its deletion, either alone or in combination with that of
Hrd1, would also be predicted to activate the UPR. Using
a plasmid construct in which transcription of the lacZ

Figure 7. Overlap in function of the ER-localized Doa10 and Hrd1 ubiquitin ligases. (A) The doa10⌬ hrd1⌬ double mutant is
hypersensitive to cadmium. Congenic cells of the indicated genotypes were spotted in 10-fold dilutions on minimal medium containing CdCl2 or on YPD and incubated for 4 d and 2 d at 30°C, respectively. (B) Induction of the unfolded protein response in a hrd1⌬
doa10⌬ mutant. Congenic cells carried the plasmid pSZ1, which contains a UPRE–lacZ reporter (Friedlander et al. 2000).
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gene was controlled by the UPRE sequence from KAR2,
a gene that is induced by the UPR (Friedlander et al.
2000), we tested these possibilities (Fig. 7B). Under the
conditions used, deletion of either HRD1 or DOA10
alone caused only modest (<twofold) induction of the
UPR. In striking contrast, if both genes were deleted,
strong induction of the UPRE–lacZ reporter was observed. These findings suggest that Hrd1 and Doa10 both
stimulate degradation of aberrant proteins in the ER. Together with the substrate specificity studies described
earlier, the data also imply that the ER/nuclear envelopelocalized Doa10 ligase can act on substrates in distinct
cellular compartments: the nucleus/cytosol and the ER
membrane.

Discussion
The genetic selection described here has led to the discovery of a novel ubiquitin–protein ligase, Doa10/Ssm4.
Remarkably, Doa10 functions not only in the degradation of the Mat␣2 transcription factor, which concentrates in the nucleus, but also in the degradation of proteins of the endoplasmic reticulum. Doa10 is a polytopic
ER membrane protein with an unusual RING finger motif that is essential both for Deg1-dependent proteolysis
in vivo and for ubiquitin ligase activity in vitro. Furthermore, our results reveal that the two ER-localized ubiquitin ligases Hrd1 and Doa10 have distinguishable substrate specificities but overlap in their ability to stimulate degradation of ERAD substrates. Loss of both Hrd1
and Doa10 causes a pronounced induction of the unfolded protein response, thereby identifying Doa10 as a
new component of this highly conserved homeostatic
mechanism.

Identification of novel genes required for Mat␣2
degradation
Our lack of knowledge about the E3s that function in
Mat␣2 ubiquitination has hampered efforts to understand the molecular basis of specificity in this pathway.
The Deg1 degradation signal in ␣2 includes the hydrophobic face of an amphipathic helix, and we have argued
that the recognition of such exposed hydrophobic surfaces is likely to be a very common mechanism of substrate discrimination by the ubiquitin system (Johnson
et al. 1998; Laney and Hochstrasser 1999). The identification of Doa10 as an E3 for Deg1-mediated ubiquitination should now allow us to dissect how these hydrophobic signals are recognized.
DOA10/SSM4 was originally identified as a suppressor
of the temperature-sensitive growth of an rna14-1 strain
(Mandart et al. 1994). Rna14 is a component of premRNA cleavage and polyadenlyation factor I and is required for viability. Disruption of SSM4 suppresses
rna14 mutants in an allele-specific manner and does not
suppress an RNA14 deletion (Rouillard et al. 2000). One
explanation for this suppression, which has ample precedent, is that the mutant Rna14-1 protein or an associ-
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ated polypeptide unfolds at the high temperature and is
degraded; inactivation of Doa10/Ssm4 reduces this degradation, allowing a partial rescue of Rna14 function.
Because the Doa10 pathway can recognize exposed hydrophobic substrate elements, as would occur with partial protein unfolding, this hypothesis is appealing, although it remains to be tested.

Doa10 is a ubiquitin–protein ligase
Multiple lines of experimental evidence lead us to conclude that Doa10 is a ubiquitin–protein ligase or E3.
First, a mutation in an E3, a substrate specificity factor,
would be expected to affect only a restricted set of substrates. In fact, Doa10 is required only for the Deg1-mediated Ubc6/Ubc7 pathway of ␣2 degradation, and it is
even not necessary for the degradation of another substrate, CPY*, that also depends on these E2s. Second,
Doa10 is absolutely required for Deg1-mediated ubiquitination in vivo. Third, Doa10 colocalizes in the cell
with the E2 enzymes that are also necessary for Deg1dependent ubiquitination. Fourth, as is true for other
yeast E3s, Doa10 levels are at least partially limiting for
the ubiquitination and degradation of its targets. Fifth,
Doa10 contains an N-terminal RING finger, a motif that
defines the larger of the two known classes of E3 ligases,
and the RING finger is necessary for Deg1-dependent
proteolysis. Finally and most directly, the Doa10 RING
domain shows ubiquitin ligase activity in a purified in
vitro system, and the structural integrity of the RING is
required for this activity in vivo and in vitro. Based on
peptide competition experiments (Fig. 6C), the Doa10
RING-containing protein is likely to bind directly to the
substrate to catalyze transfer of ubiquitin from the E2.
We have not yet succeeded in reconstituting Deg1mediated ubiquitination in a fully homologous in vitro
system. Because it is a relatively large integral membrane protein, full-length Doa10 may be difficult to manipulate in vitro. However, if the substrate- and E2-binding domains of the E3 can be defined, it might be possible
to construct a mini-Doa10 derivative capable of directing
Deg1-dependent substrate ubiquitination in vitro. As described in the next section, several predicted structural
motifs in Doa10 offer clues as to what these key domains
might be.

Significance of Doa10 structural motifs
The RING finger ubiquitin ligases are thought to provide
a platform for the simultaneous binding of E2 and substrate, thereby enhancing ubiquitin transfer. An unusual
feature of the DOA pathway is that it requires two distinct E2 isozymes, Ubc6 and Ubc7. Yeast two-hybrid
analysis had previously suggested a weak physical interaction (direct or indirect) between these two E2s (Chen
et al. 1993). Certain structural features of Doa10 suggest
how it might interact with both Ubc6 and Ubc7. It is
tempting to speculate that the RING finger functions to
recruit Ubc7. The Hrd1 E3 binds Ubc7 in vivo, and this
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interaction requires the intact Hrd1 RING finger (Bays et
al. 2001). In the crystal structure of the UbcH7–c-Cbl
complex, the c-Cbl RING makes direct contacts with the
E2 (Fig. 2A; Zheng et al. 2000). Doa10 also contains a
putative WW motif. The ligand specificity of this motif
has been extensively characterized. The major class of
ligands that can bind WW motifs is the proline-rich sequence PPxY, and Ubc6 is one of only 18 proteins (and
the only E2) predicted from the yeast genome to contain
a PPxY motif (Chang et al. 2000). We suggest that a noncanonical E3–E2 interaction between Doa10 and Ubc6,
together with Doa10 RING association with Ubc7, allows simultaneous binding of Ubc6 and Ubc7 to the E3
in the ER membrane, as depicted schematically in Figure
8. Our data and those of others demonstrate that the E2
Ubc7 functions with two different E3s, Doa10 and Hrd1.
Moreover, Ubc7 works both with Ubc6 to ubiquitinate
Deg1-containing substrates and without Ubc6 to ubiquitinate Hrd1 substrates. These findings reinforce the idea,
proposed earlier (Chen et al. 1993), that formation of different E2 and E2/E3 combinations would greatly expand
the range of substrate specificities in the ubiquitin system.
If Doa10 is indeed principally responsible for substrate
discrimination, how might it recognize the Deg1 signal?
As noted, the key determinant in Deg1 is an amphipathic segment with the potential to form a coiled-coil
structure. It is intriguing in this regard that Doa10 has at
its very N terminus a short stretch that is predicted to
form a coiled coil (Lupas et al. 1991). Potentially, this
could function as a sensor domain in Doa10 that allows
it to interact with hydrophobic degradation signals, particularly those that are part of amphipathic helices, although other Doa10 elements may function in substrate
recognition as well.
Many of the ER targets of the Hrd1 ubiquitin ligase
appear to be retrotranslocated out of the ER via the Sec61
translocon (Plemper and Wolf 1999). Although it will be
important to determine whether any ER substrates of
Doa10 are also extracted via Sec61, Doa10-dependent
degradation of the integral ER membrane protein Ubc6
has been shown to be independent of Sec61 (Walter et al.

Figure 8.

Model for Doa10 function. See text for details.

2001). Doa10 is a large protein that appears to have at
least ten transmembrane segments, and this organization is highly conserved (Fig. 2C). This suggests that the
transmembrane topology has an important function(s)
that goes beyond simply tethering the enzyme to the
membrane. An attractive idea is that transmembrane
segments in Doa10 contribute to a protein exit channel
that allows retrotranslocation of substrates such as Ubc6
from the ER. It is also plausible that multiple transmembrane domains are required to coordinate the binding and
proper orientation of E2s and substrate.
Overlapping and unique functions of two ER
ubiquitin–protein ligases
Hrd1 and Doa10 are both RING finger E3s that localize
to the ER/nuclear envelope. Hrd1 is important for the
degradation of a number of ERAD substrates, but there
are exceptions (Hill and Cooper 2000; Wilhovsky et al.
2000), which suggested that other ER ubiquitin ligases
might exist. Indeed, we have now found that Doa10 is
essential for the degradation of at least one Hrd1-independent ERAD substrate, Ubc6, and there are undoubtedly additional ER targets for this E3. Defects in ERAD
have recently been linked to induction of the UPR (Friedlander et al. 2000; Travers et al. 2000). When Friedlander
et al. (2000) compared UPR induction in hrd1⌬ and
ubc1⌬ ubc7⌬ cells, a much smaller effect was seen in the
former strain. Loss of the E2s Ubc1 and Ubc7 eliminates
all known ER-specific protein ubiquitination pathways,
so this result implied that an ERAD ubiquitin ligase
other than Hrd1 was needed for full UPR induction. Our
data strongly suggest that Doa10 is such an E3. Consistent with this, UPR induction in doa10⌬ hrd1⌬ was
nearly as great as that seen when wild-type cells were
treated with 4 mM dithiothreitol, an inducer of the UPR
(Friedlander et al. 2000; data not shown). Notably, transcriptional up-regulation of DOA10 in wild-type cells on
UPR induction is comparable to that of UBC7 (Travers
et al. 2000), and Ubc7 levels are known to go up as part
of the UPR (Friedlander et al. 2000).
Because Doa10 and Hrd1 localize similarly, it is not
yet clear how specific substrates are targeted to one E3 or
the other. The two E3s (or E3/E2 complexes) might recognize distinct structural features of substrates, or they
might localize to distinct microdomains within the ER/
nuclear envelope. The ER localization of Doa10 and its
cognate E2s raises the interesting question of how a substrate such as Mat␣2, which is primarily nuclear, gains
access to the Doa10 ubiquitination complex. Three general models, which are not mutually exclusive, can be
proposed. First, ␣2 may only be subject to Doa10-mediated ubiquitination between the time of its synthesis
and its import into the nucleus. We do not favor this idea
because the degradation kinetics of the steady-state pool
of ␣2 are comparable to those of newly synthesized repressor (J. Laney and M. Hochstrasser, unpubl.), and
most of ␣2 at steady state is in the nucleus. In another
model, Doa10 (and Ubc6 and Cue1/Ubc7) would diffuse
from the outer to the inner nuclear membrane (the two
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fuse at the nuclear pores), where the ubiquitination complex would have direct access to nuclear-localized ␣2.
Such movement of membrane proteins to the inner
membrane occurs for a number of proteins, but a size
limit of ∼60 kD for the cytoplasmic domains of such
proteins appears to exist, presumably because of the restricted space within the lateral channels of nuclear pore
complexes (Worman and Courvalin 2000). We do not
know the precise topology of Doa10, but transmembrane
prediction algorithms suggest a fairly large cytoplasmically disposed component, which might restrict movement to the inner membrane. Finally, substrates such as
␣2 might be transported out of the nucleus to access the
ER-embedded Doa10 complex. Other proteins, such as
p53, have been shown to require nuclear export for efficient degradation (Liang and Clarke 2001). Experiments
to distinguish among these possibilities are underway.
The human ortholog of DOA10 maps to the cri-du-chat
critical region
At present there are no published reports on any of the
Doa10-like proteins predicted from other genomes.
However, the human TEB4 gene, the likely homolog of
DOA10 (see Fig. 2) maps to the cri-du-chat critical region
on chromosome 5p15.2. Segmental aneuploidy of this
region causes a relatively common genetic disorder (at
least one in 50,000 live births) that is associated with
severe mental retardation and developmental delay
(Mainardi et al. 2001). Deficiencies for multiple genes in
this region appear to contribute to the disease phenotype, so it has been difficult to evaluate the contribution
of individual genes. It is intriguing that another disease
characterized by severe mental retardation and some of
the same craniofacial abnormalities, Angelman syndrome, has also been associated with a defective ubiquitin ligase, the HECT E3 E6-AP (Kishino et al. 1997). Our
work on Doa10 leads to the hypothesis that defective
protein ubiquitination at the ER/nuclear envelope is important for the etiology of cri-du-chat syndrome, although the precise contribution of TEB4 to this disease
remains to be firmly established. Interestingly, the
mouse protein axotrophin has a RING-CH domain similar to that of Doa10 and is required for normal brain
development: Disruption of the axotrophin gene results
in callosal agenesis and neural degeneration (see GenBank NP_065600).
Several other neurodegenerative disorders have been
linked recently to defective ubiquitin/proteasome-dependent proteolysis, including ERAD. Parkin, a RING
finger E3 that is mutated in an inherited form of Parkinson’s disease, was shown to interact with the human
orthologs of Ubc6 and Ubc7 and to suppress cell death
induced by unfolded protein accumulation in the ER
(Imai et al. 2001). Aggregation of aberrant huntingtin
protein, which is associated with Huntington’s disease,
has been correlated with a block to the degradation of a
Ubc6/Ubc7-dependent proteolytic test substrate in vivo
(Bence et al. 2001). The degradation signal of this substrate was initially defined in yeast (Gilon et al. 1998).
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We have found that yeast proteins bearing this class of
signals are targeted by the Doa10 ubiquitin ligase (data
not shown). It will therefore be of interest to determine
whether defects in the human Doa10 ortholog are linked
to neurodegenerative diseases such as Huntington’s.
Materials and methods
Bacterial and yeast methods
Rich (YPD) and minimal (SD) media were prepared as described
(Ausubel et al. 1989). Standard methods were used for genetic
analysis of yeast. The E. coli strains used in this study were
JM101, MC1061, BL21(DE3), and DH10B, and bacterial methods and media were as described (Ausubel et al. 1989).
Construction of yeast strains
For a complete list of strains, see Table 2. The wild-type strain
MHY1410 was prepared by integrating pRS303 (Sikorski and
Hieter 1989) into the his3 locus of JY112, and MHY1411 was
prepared by integrating pRS304 (Sikorski and Hieter 1989) into
the trp1 locus of JY113. MHY1412 was a segregant from a cross
between MHY551 and JY112. MHY1690 was derived from a
cross between MHY551 and MHY1657; MHY1651, from a cross
between MHY1631 and MHY1366; MHY1648, from a cross between MHY1631 and MHY513; and MHY1670, from a cross
between MHY1631 and MHY496.
MHY1631 was generated by disrupting the entire DOA10
open reading frame (ORF) with the HIS3 gene via polymerase
chain reaction (PCR)-mediated homologous recombination in
MHY501 (Baudin et al. 1993). Primer sequences are available on
request. Proper integration of the HIS3 fragment was determined by colony PCR, and the strain was backcrossed to
MHY500 to show single site integration. MHY1657 was made
using a C-terminal myc-tagging cassette (a gift of R. Verma,
Caltech, Pasadena, CA). For this, a PCR product was generated
that encoded the C terminus of Doa10 in frame with a sequence
encoding nine copies of a c-myc epitope followed by the S.
pombe his5+ gene, which functionally complements the S. cerevisiae HIS3 gene. This DNA fragment was integrated into
MHY501, and correct integration was verified as above.
MHY1657 was shown to complement the doa10 phenotype in
crosses to several doa10 strains isolated in the screen.
MHY1658 was made using a C-terminal GFP-tagging cassette
(Longtine et al. 1998). A PCR product that contained the 3⬘ end
of the DOA10 ORF in frame with the GFP ORF followed by the
S. kluyveri HIS3 gene was generated from the plasmid pFA6aGFP(S65)HIS3MX6. The DOA10-GFP allele fully complemented the doa10 degradation defect.
To construct the RING finger mutation in MHY2091, a twopart PCR method was used (Ausubel et al. 1989). Primers were
used to amplify a 5⬘ segment of the DOA10 locus beginning 393
bp upstream of the translational start site and extending
through the Glu45 codon, with the downstream primer introducing the Ser 39 mutation. A second pair of primers was used
to amplify an internal fragment of DOA10, encoding Asp 32 to
Arg 400, with the upstream primer introducing the Ser 39 mutation. The two fragments were combined by a second PCR step
and subcloned into YIplac211, and the mutation was confirmed
by DNA sequencing. The linearized plasmid was transformed
into MHY1657, and uracil prototrophs were then plated on
5-fluoroorotic acid, which is toxic to cells expressing URA3, to
select for plasmid excision. Strains were screened for the mutation by amplification of the 5⬘ region of the DOA10 ORF
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Table 2.

Strains used in present study

Strain
a

JY112
JY113a
MHY496b
MHY498b
MHY500b
MHY501b
MHY503b
MHY513b
MHY551b
MHY552b
MHY884c
MHY1364d
MHY1366
MHY1367
MHY1410
MHY1411
MHY1412
MHY1631
MHY1648
MHY1651
MHY1657
MHY1658
MHY1669e
MHY1670
MHY1690
MHY1703
MHY1740
MHY1745
MHY1747
MHY2091
MHY2093f
MHY2094
MHY2095

Genotype
␣ his3-⌬200 leu2-⌬1⬋LEU2-Deg1-lacZ ura3-52 lys2-801⬋LYS2-Deg1-URA3 trp1-⌬63
a his3-200 leu2⌬1⬋LEU2-Deg1-lacZ ura3-52 lys2⬋LYS2-Deg1-URA3 trp1-⌬63
MHY501 with ubc6-⌬1⬋HIS3
MHY501 with ubc4-⌬1⬋HIS3
a his3-200 leu2-3,112 ura3-52 lys2-801 trp1-1
␣ his3-200 leu2-3,112 ura3-52 lys2-801 trp1-1
MHY501 with ubc4-⌬1⬋HIS3 ubc6-⌬1⌬⬋HIS3
MHY500 with ubc4-⌬1⬋HIS3
MHY500 with ubc7⬋LEU2
MHY501 with ubc6-⌬1⬋HIS3 ubc7⬋LEU2
MHY500 with doa4⌬⬋leu2⬋HIS3
MHY501 with cue1⌬⬋HIS3
MHY500 with prc1-1
MHY500 with cue1⌬⬋HIS3 ubc6⌬⬋TRP1 ubc7⬋LEU2 prc1-1
␣ his3-200⬋pRS303(HIS3) leu2-⌬1⬋LEU2-Deg1-lacZ ura3-52 lys2-801⬋LYS2-Deg1-URA3 trp1-⌬63
a his3-200 leu2-⌬1⬋LEU2-Deg1-lacZ ura3-52 lys2-801⬋LYS2-Deg1-URA3 trp1-⌬63⬋pRS304(TRP1)
␣ his3-⌬200 leu2-⌬1⬋LEU2-Deg1-lacZ ura3-52 lys2-801⬋LYS2-Deg1-URA3 trp1 ubc7⬋LEU2
␣ his3-200 leu2-3,112 ura3-52 lys2-801 trp1-1 doa10⌬⬋HIS3
␣ his3-200 leu2-3,112 ura3-52 lys2-801 trp1-1 doa10⌬⬋HIS3 ubc4⬋HIS3
␣ his3-200 leu2-3,112 ura3-52 lys2-801 trp1-1 doa10⌬⬋HIS3 prc1-1
␣ his3-200 leu2-3,112 ura3-52 lys2-801 trp1-1 DOA10-myc9⬋his5+
␣ his3-200 leu2-3,112 ura3-52 lys2-801 trp1-1 DOA10-GFP⬋HIS3
MHY501 with hrd1⌬⬋LEU2
␣ his3-200 leu2-3,112 ura3-52 lys2-801 trp1-1 doa10⌬⬋HIS3 ubc6⌬⬋HIS3
␣ his3-200 leu2-3,112 ura3-52 lys2-801 trp1-1 ubc7⬋LEU2 DOA10-myc9⬋his5+
MHY501 with hrd1⌬⬋LEU2 doa10⌬⬋HIS3
␣ his3-200 leu2-⌬1⬋LEU2-Deg1-lacZ ura3-52 lys2⬋LYS2-Deg1-URA3 trp1-⌬63 doa11-1 doa12-1
␣ his3-200 leu2-⌬1⬋LEU2-Deg1-lacZ ura3-52 lys2⬋LYS2-Deg1-URA3 trp1-⌬63 doa11-1
a his3-200 leu2-⌬1⬋LEU2-Deg1-lacZ ura3-52 lys2-801⬋LYS2-Deg1-URA3 trp1-⌬63⬋pRS304(TRP1) doa12-1
␣ his3-200 leu2-3,112 ura3-52 lys2-801 trp1-1 doa10-C39S-myc9⬋his5+
a leu2-⌬1⬋LEU2-Deg1-lacZ ura3-52 lys2-801 rpn4⬋URA3(mTn3)
␣ his3-200 leu2-⌬1⬋LEU2-Deg1-lacZ ura3-52 lys2-801⬋LYS2-Deg1-URA3 trp1-1 doa10-2
␣ his3-200 leu2-⌬1⬋LEU2-Deg1-lacZ ura3-52 lys2-801⬋LYS2-Deg1-URA3 trp1-1 doa10-3

a

J. Laney and M. Hochstrasser, unpubl.
Chen et al. 1993.
c
M. Hochstrasser, unpubl.
d
Biederer et al. 1997.
e
Bays et al. 2001.
f
Swanson and Hochstrasser 2000.
b

followed by DNA sequencing to identify the doa10–C39S–myc9
allele.
Plasmid constructions
DOA10/SSM4 is toxic to E. coli (Mandart et al. 1994), so fulllength DOA10 plasmids were constructed in yeast. pGPD–
DOA10 was constructed by gap repair from the chromosomal
copy of DOA10. The 5⬘ end of the DOA10 ORF from the start
codon to Pro 167 was PCR amplified, as was the 3⬘ end of the
ORF from Arg 1250 to the stop codon. These two fragments
were inserted into separate pGEM-T/EASY vectors (Promega).
The 5⬘ DOA10 fragment was first subcloned into the p426GPD
vector (Mumberg et al. 1995) using BamHI and HindIII sites, and
the 3⬘ DOA10 fragment was then subcloned into the modified
plasmid using HindIII and SalI sites. The resulting plasmid,
which lacks sequences encoding Doa10 residues 168 to 1249,
was linearized with HindIII and transformed into MHY501,
with selection for uracil prototrophy. Gap repair was verified by
colony PCR.
To express the Doa10 RING domain in E. coli BL21(DE3) as a

GST-Speptide fusion, a segment of DOA10 encoding the first 112
residues of Doa10 was amplified by PCR using primers that
allowed subsequent in-frame fusion with the sequence encoding
GST-Speptide in pET-42b(+) (Novagen). The entire insert was sequenced to verify the absence of errors.
YCplac22-HA-UBC7 was constructed by a two-step PCR procedure similar to that described above. The plasmid insert contained 200 bp upstream of the UBC7 translational start site, the
sequence encoding the HA epitope fused to the UBC7 ORF, and
150 bp of sequence downstream of the UBC7 stop codon. The
fragment was initially ligated into the vector pGEM-T/Easy and
was subsequently excised as an EcoRI fragment and subcloned
into YCplac22 (Gietz and Sugino 1988). pHA-UBC7 was shown
to reverse the cadmium hypersensitivity and rapid growth on
medium lacking uracil, which characterized the ubc7⌬ strain
MHY1412.
Isolation of doa mutants
MHY1410, MHY1411, and MHY1412 strains (the last as a control that was not subjected to mutagenesis) were grown over-

GENES & DEVELOPMENT

2671

Downloaded from genesdev.cshlp.org on August 9, 2011 - Published by Cold Spring Harbor Laboratory Press

Swanson et al.

night in YPD and then mutagenized with ethyl methanesulfonate (Kodak) to ∼28% survival (∼3 × 106 survivors). Half the
cells were plated on uracil drop-out plates immediately, and half
were resuspended in SD complete medium, grown for 4 h at
30°C, and then plated on plates lacking uracil. Cells were grown
for 1 to 2 d at 30°C, and the first 960 colonies that appeared were
picked into 96-well microtiter plates. Mutants were retested by
streaking on plates lacking uracil to confirm the Ura+ phenotype.
The mutants were first tested for their ability to complement
the following known mutants of the Deg1-mediated degradation pathway: MHY552 (ubc6⌬ ubc7⌬), MHY884 (doa4⌬),
MHY1364 (cue1⌬), and MHY2093 (rpn4). Mutants of opposite
mating type to the tester strain were spotted into fresh 96-well
plates containing YPD. The tester strain was then spotted into
the same plates, and mating was allowed to occur overnight at
30°C without agitation. Cells were pelleted and resuspended in
cold sterile water. After incubating for 2 to 3 h at 4°C to slow
cell growth, cells were spotted onto drop-out plates that were
selected for diploid prototrophs. Plates were incubated overnight at 30°C, and the diploids were tested for complementation
of the Deg1–Ura3 degradation defect by streaking onto minimal
plates lacking both uracil and the nutrients required to maintain the selection for diploid cells. Complementation of
MHY2093 were performed on 1 µg/mL canavanine sulfate. Mutants that did not fall into one of the tested groups were then
crossed to one another and tested in the same manner as above
for placement into new groups. Representative mutants were
backcrossed to determine the number of unlinked mutations
responsible for the degradation defect and to check whether
they were recessive or dominant.
Identification of the DOA10 gene
The DOA10 gene was localized by genetic mapping of a representative doa10 mutant allele. First, the doa10-2 allele was localized to a specific chromosome by the 2-µm mapping method.
After mating doa10-2 to the 2-µm tester strains, the resulting
diploids were assayed quantitatively for ␤gal activity using Onitrophenyl ␤-D-galactopyranoside (ONPG) as the substrate
(Ausubel et al. 1989). Only diploids from the cross to the strain
with the 2-µm plasmid in chromosome IX showed the recessive
doa10 trait of increased Deg1–␤gal activity (6 out of 19 tests,
31%). Subsequently, the doa10-2 Deg1-URA3 mutant was
crossed to a strain with an integrated Deg1-URA3 marker and
the ulp2⌬⬋HIS3 allele on chromosome IX (Li and Hochstrasser
2000). After sporulation, 96 full tetrads (and >60 incomplete
tetrads) were tested for marker segregation. No recombination
between the two markers was seen, indicating very tight linkage of doa10-2 and ulp2⌬⬋HIS3. A strain with a deletion of the
nearby SSM4 gene was constructed and mated to mutants
doa10-1 through doa10-5; the resulting diploids all grew rapidly
on uracil drop-out plates.

at pH 7.5, and 1 mM MgCl2) plus protease inhibitors. Unlysed
cells and cell debris were pelleted at 600g for 6 min, and the
supernatant was divided into separate tubes that were subjected
to one of the following treatments for 1 h on ice: (1) 2.5 M urea,
0.1 M Na2CO3 (pH 11.5), 1% Triton X-100, and 0.5 M NaCl or
(2) 0.5 M NaCl. Samples were then separated into pellet and
supernatant fractions by centrifugation at 100,000 rpm for 1 h at
4°C. Pellets were washed once with fractionation buffer containing the original additions, as appropriate, and resuspended
in fractionation buffer. Proteins were precipitated in 10% trichloroacetic acid for 30 min on ice, pelleted, washed in ethanol,
resuspended in gel loading buffer, and evaluated by immunoblotting.
Pulse-chase and immunoblot analyses
Pulse-chase analyses were performed as described (Chen et al.
1993). Deg1–␤gal and Leu–␤gal fusions were immunoprecipitated with anti-␤gal (Organon Teknika); Mat␣2, with anti-␣2
(Chen et al. 1993); and CPY*, with anti-CPY antibodies (gift
from N. Segev, University of Chicago). Immunoblot analysis
was performed as described (Swaminathan et al. 1999), with
antibody binding detected with enhanced chemiluminescence
reagents (Amersham). Doa10–myc was visualized with an antimyc monoclonal antibody (9E10, Roche); Pgk1, with anti-PGK
(Molecular Probes); Kar2, with an anti-Kar2 antiserum (gift of J.
Broach, Princeton University, NJ); Ubc7-HA, with an anti-HA
antibody (16B12, Berkeley Antibody); and Ubc6, with anti-Ubc6
(gift of T. Sommer, Max Delbrück Center, Berlin, Germany). For
Deg1–␤gal immunoprecipitation/anti-ubiquitin immunoblotting, 20 mM N-ethylmaleimide was included in the lysis buffer.
Precipitated proteins were resolved by SDS-PAGE and subjected
to immunoblotting with anti-ubiquitin (hybridoma P4G7-H11;
gift of D. Gottschling, Fred Hutchinson Cancer Research Center, Seattle, WA).
In vitro analysis of Doa10RING-mediated
protein ubiquitination
Following the procedure of Bays et al. (2001), a typical 20 µL
reaction contained the following purified components: 0.5 µg
yeast Uba1 (Boston Biochem); 0.5 µg human Ubc4-His6 (Bays et
al. 2001), which was purified from an E. coli BL21(DE3) lysate
with a Talon affinity resin; 2.5 µg of bovine ubiquitin (Sigma);
10 mM ATP; 1.5 µg of S-protein (Sigma); and 1.5 µg of GST-S–
Doa10RING, which was purified on glutathione-Sepharose and
then dialyzed. Reactions were performed in 50 mM Tris-HCl
(pH 7.5), 2.5 mM MgCl2, and 0.5 mM DTT for 4 h at 30°C and
were stopped by addition of SDS gel loading buffer and heating
for 3 min at 100°C. Proteins were resolved on 16.5% TricineSDS–polyacrylamide gels and visualized by anti-ubiquitin immunoblotting.
Fluorescent staining of yeast cells

Yeast subcellular fractionation
Yeast were grown to mid-log phase, and five OD600 equivalents
were harvested and washed in spheroplast buffer (1 M sorbitol,
20 mM sodium phosphate at pH 7.5, and 75 mM NaCl). Cells
were incubated for 10 min at 30°C in 1 mL of spheroplast buffer
and 30 mM dithiothreitol (DTT) and then were spun down and
resuspended in spheroplast buffer and 2 mM DTT. After addition of 70 µg of zymolase 100T (ICN), the cells was incubated
for 20 min at 30°C, washed in spheroplast buffer, and lysed by
glass-bead shearing for 1 min in 1 mL of fractionation buffer
(200 mM D-mannitol, 75 mM NaCl, 20 mM sodium phosphate
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Immunofluorescent staining was performed as described previously (Rossanese et al. 2001). Samples were visualized on an
Axioplan microscope (Carl Zeiss) equipped with a 100× PlanApo 1.4 NA objective lens and with band-pass filters for visualizing Hoechst 33258, fluorescein, and Texas red fluorescence.
Secondary antibodies (Molecular Probes) for primary antibody
detection were goat anti-rabbit IgG coupled to Texas Red and
goat anti-mouse IgG coupled to Alexa 488. For Doa10–GFP localization, MHY1658 cells were grown to mid-log phase and
then washed twice and resuspended in sterile water; 5 µL were
spotted on a slide and spread with a coverslip. The GFP chro-
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mophore was excited with a 488-nm laser and visualized with a
505- to 550-nm bandpass filter on an Zeiss LSM 510 confocal
microscope.
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